You are here

Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Tokyo Heat Center
Tokyo, , 141-0001 Japan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Alzheimer Disease, Healthy
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
20 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

1. Men aged 20 to 45 years, or greater than 65 years, inclusive, at screening and who
agree to use a medically acceptable form of contraception during the study and to
continue its use for 12 weeks after test article administration.

2. Healthy as determined by the investigator on the basis of medical history, physical
examination, clinical laboratory tests, vital sign measurements and 12-lead
electrocardiogram (ECG).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

1. Presence or history of any disorder that may prevent the successful completion of the
study.

2. Any history or presence of chronic respiratory disorder or disease including but not
limited to asthma, sleep apnea, or chronic obstructive pulmonary disease (COPD).

NCT00719394
Pfizer
Completed
Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now